Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12005074 Extrahepatic delivery

Patent 12005074 was granted and assigned to Alnylam Pharmaceuticals on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
0
Date Filed
May 3, 2023
0
Date of Patent
June 11, 2024
0
Patent Applicant
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
0
Patent Application Number
18311484
0
Patent Citations
‌
US Patent 7851615 Lipophilic conjugated iRNA agents
0
‌
US Patent 7037646 Amine-derivatized nucleosides and oligonucleosides
0
‌
US Patent 7101993 Oligonucleotides containing 2′-O-modified purines
0
‌
US Patent 7723509 IRNA agents with biocleavable tethers
0
‌
US Patent 7741472 Polynucleotide containing a phosphate mimetic
0
‌
US Patent 7745608 Modified iRNA agents
0
‌
US Patent 8110674 Therapeutic compositions
0
‌
US Patent 8158593 GPR17 modulators, method of screening and uses thereof
0
‌
US Patent 8507661 Modified iRNA agents
0
‌
US Patent 8962580 Chemical modifications of monomers and oligonucleotides with cycloaddition
0
•••
Patent Inventor Names
Stuart Milstein
0
Alexander V. Kel'In
0
Kirk Brown
0
Klaus Charisse
0
Rubina G. Parmar
0
Kevin Fitzgerald
0
Muthiah Manoharan
0
Adam Castoreno
0
Kallanthottathil G. Rajeev
0
Jayaprakash K. Nair
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12005074
0
Patent Primary Examiner
‌
J. E. Angell
0
CPC Code
‌
C12N 2310/14
0
‌
C12N 15/1138
0
‌
C12N 15/1137
0
‌
C12N 2310/3515
0
‌
A61K 9/0019
0
‌
A61K 31/713
0
‌
A61K 47/543
0

Find more entities like US Patent 12005074 Extrahepatic delivery

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.